172 related articles for article (PubMed ID: 7507458)
1. Hepatitis C virus antibody in coagulopathic patients: ELISA and RIBA methods.
Chistolini A; Filoni V; Dragoni F; Piro L; Mazzucconi MG; Isacchi G
Haematologica; 1993; 78(4):252-4. PubMed ID: 7507458
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
3. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
[TBL] [Abstract][Full Text] [Related]
5. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C infection in BMT patients.
Kolho E; Ruutu P; Ruutu T
Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
[TBL] [Abstract][Full Text] [Related]
8. [Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients].
Albornoz A; Esaa R; Rodríguez de Leon L; Mujica C
G E N; 1993; 47(3):136-8. PubMed ID: 7509301
[TBL] [Abstract][Full Text] [Related]
9. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
Héjjas M; Medgyesi G; Hajnal A
Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
[TBL] [Abstract][Full Text] [Related]
10. Comparative results in detection of HCV antibodies by using a rapid HCV test, ELISA and immunoblot.
Poovorawan Y; Theamboonlers A; Chumdermpadetsuk S; Thong CP
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):647-9. PubMed ID: 7545315
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
[TBL] [Abstract][Full Text] [Related]
12. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
13. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
Imamura S
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies against hepatitis C virus. Experience with a second generation test].
Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
G E N; 1991; 45(3):183-9. PubMed ID: 1726913
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis C virus serology in patients affected with congenital coagulation defects: a comparative study using three second generation ELISA tests.
Paolini R; Marson P; Vicarioto M; Ongaro G; Viero M; Girolami A
Transfus Sci; 1994 Sep; 15(3):303-11. PubMed ID: 10184457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
